摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

benzyl (3-nitro-5,6,7,8-tetrahydroquinolin-5-yl)carbamate | 884306-54-1

中文名称
——
中文别名
——
英文名称
benzyl (3-nitro-5,6,7,8-tetrahydroquinolin-5-yl)carbamate
英文别名
benzyl N-(3-nitro-5,6,7,8-tetrahydroquinolin-5-yl)carbamate
benzyl (3-nitro-5,6,7,8-tetrahydroquinolin-5-yl)carbamate化学式
CAS
884306-54-1
化学式
C17H17N3O4
mdl
——
分子量
327.34
InChiKey
LQFZOPYIOUZHPY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    24
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    97
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS<br/>[FR] CARBOXAMIDES UTILISÉES EN TANT QU'INHIBITEURS DE PROTÉASE SPÉCIFIQUE DE L'UBIQUITINE
    申请人:FORMA THERAPEUTICS INC
    公开号:WO2019032863A1
    公开(公告)日:2019-02-14
    The present disclosure relates to modulators, such as inhibitors, of at least one pathway chosen from USP28 and USP25, pharmaceutical compositions comprising the inhibitors, and methods of using the inhibitors. The modulators, such as inhibitors, of at least one pathway chosen from USP28 and USP25 can be useful in the treatment of cancers, among other ailments.
    本公开涉及调节剂,如抑制剂,至少选择自USP28和USP25中的一条途径的药物组合物包括这些抑制剂,以及使用这些抑制剂的方法。这些调节剂,如抑制剂,至少选择自USP28和USP25中的一条途径,可用于治疗癌症等疾病。
  • Microwave-Assisted Synthesis of Novel (5-Nitropyridin-2-yl)alkyl and (5-Nitropyridin-3-yl)alkyl Carbamates
    作者:Christophe Henry、Andreas Haupt、Sean C. Turner
    DOI:10.1021/jo802439d
    日期:2009.3.6
    straightforward approach to novel (5-nitropyridin-2-yl)alkyl and (5-nitropyridin-3-yl)alkyl carbamate building blocks is presented in this study. Their construction is achieved by condensation of N-carbamate α- and β-amino carbonyl derivatives with 1-methyl-3,5-dinitro-2-pyridone 1 under microwave irradiation. Judiciously chosen modifications in the nature of the parent carbonyl starting material has influenced
    在这项研究中提出了一种新颖的方法,以新颖的(5-硝基吡啶-2-基)烷基和(5-硝基吡啶-3-基)烷基氨基甲酸酯结构单元。它们的构造是通过在微波辐射下使N-氨基甲酸酯α-和β-氨基羰基衍生物与1-甲基-3,5-二硝基-2-吡啶酮1缩合而实现的。母体羰基原料性质的明智选择的修饰影响了反应的区域化学结果,并允许有效地获得新型的含氮支架。具有相同形态相似性的化合物已收集到三个在单个结构参数上彼此不同的库中。
  • [EN] ARYLSULFONYLMETHYL OR ARYLSULFONAMIDE SUBSTITUTED AROMATIC COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MADULATION OF THE DOPAMINE D3 RECEPTOR<br/>[FR] COMPOSES AROMATIQUES D'ARYLSULFONYLMETHYLE OU D'ARYLSULFONAMIDE SUBSTITUES PERMETTANT DE TRAITER DES TROUBLES REPONDANT A UNE MODULATION DU RECEPTEUR D3 DE LA DOPAMINE
    申请人:ABBOTT GMBH & CO KG
    公开号:WO2006040178A1
    公开(公告)日:2006-04-20
    The present invention relates to aromatic compounds of the formula (I), wherein Ar is phenyl or an aromatic 5- or 6-membered C-bound heteroaromatic radical, wherein Ar may carry 1 radical Ra and wherein Ar may also carry 1 or 2 radicals Rb; X is N or CH; Y is O, S, -CH=N-, -CH=CH- or -N=CH-; A is CH2i O or S; E is CR6R7 or NR 3; R1 is C1-C4-alkyl, C3-C4-cycloalkyl, C3-C4-cycloalkylmethyl, C3-C4-alkenyl, fluorinated C1-C4-­alkyl, fluorinated C3-C4-cycloalkyl, fluorinated C3-C4-cycloalkylmethyl, fluorinated C3-C4­-alkenyl, formyl or C,-C3-alkylcarbonyl; R1a is H, C2-C4-alkyl, C3-C4-cycloalkyl, C3-C4-alkenyl, fluorinated C1-C4-alkyl, fluorinated C3-C4 -cycloalkyl, or R1a and R2 together are (CH2)n with n being 2 or 3, or R1a and R2a together are (CH2)n with n being 2 or 3; R2 and R2a are independently of each other H, CH3, CH2F, CHF2 or CF3; R3 is H or C1-C4-alkyl; R6, R7 independently of each other are selected from H, C1-C2-alkyl and fluorinated C1-C2-alkyl; and the physiologically tolerated acid addition salts thereof. The invention also relates to the use of a compound of the formula I or a pharmaceutically acceptable salt thereof for preparing a pharmaceutical composition for the treatment of a medical disorder susceptible to treatment with a dopamine D3 receptor ligand.
    本发明涉及式(I)的芳香族化合物,其中Ar是苯基或芳香族5-或6-成员C-键合杂芳基,其中Ar可以携带1个基团Ra,Ar也可以携带1个或2个基团Rb;X是N或CH;Y是O、S、-CH=N-、-CH=CH-或-N=CH-;A是CH2i、O或S;E是CR6R7或NR3;R1是C1-C4-烷基、C3-C4-环烷基、C3-C4-环烷基甲基、C3-C4-烯基、氟代C1-C4-烷基、氟代C3-C4-环烷基、氟代C3-C4-环烷基甲基、氟代C3-C4-烯基、甲酰基或C,-C3-烷基羰基;R1a是H、C2-C4-烷基、C3-C4-环烷基、C3-C4-烯基、氟代C1-C4-烷基、氟代C3-C4-环烷基,或R1a和R2一起是(CH2)n,其中n为2或3,或R1a和R2a一起是(CH2)n,其中n为2或3;R2和R2a彼此独立地是H、CH3、CH2F、CHF2或CF3;R3是H或C1-C4-烷基;R6、R7彼此独立地选自H、C1-C2-烷基和氟代C1-C2-烷基;以及其生理耐受的酸盐。该发明还涉及使用式I的化合物或其药学上可接受的盐制备用于治疗对多巴胺D3受体配体敏感的医疗疾病的药物组合物。
  • WO2022/111636
    申请人:——
    公开号:——
    公开(公告)日:——
  • [EN] POTENT SMALL MOLECULE INHIBITORS OF AUTOPHAGY, AND METHODS OF USE THEREOF<br/>[FR] INHIBITEURS DE L'AUTOPHAGIE À PETITES MOLÉCULES, EFFICACES, ET LEURS PROCÉDÉS D'UTILISATION
    申请人:HARVARD COLLEGE
    公开号:WO2014145512A3
    公开(公告)日:2014-12-31
查看更多